http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2652125-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f96834e57d8e054e429b524c85d68c54
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-50
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-50
filingDate 2017-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6de83ac040f783438578728463289c68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87af89f99dbf31cdca3a71cc8f0db7be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f3b9b8bcf7d0a8f2d7239ccbede1796
publicationDate 2018-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2652125-C1
titleOfInvention Method of producing 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride
abstract FIELD: chemistry. n SUBSTANCE: invention relates to organic chemistry, specifically to a method of producing 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, which includes condensation in the medium of phosphorus oxychloride of 2,6-dichloroaniline with 1-acetylimidazolidone-2, obtained by acetylation of ethylene urea with acetic anhydride. Acetylation is carried out at a temperature of 80–90 °C and holding for 3–4 hours, condensation is carried out for 3–4 hours at a temperature of 90–100 °C. After the condensation reaction, excess phosphorus oxychloride is distilled from the reaction mass, the residue is mixed with water and ice, the resulting aqueous solution is diacetylated or the reaction mass is mixed with water and ice, the resulting acidic solution is diacetylated. n EFFECT: novel, advanced and safer method is developed for use on an industrial scale, which simultaneously increases the yield and purity of the desired product – 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, which is used in medicine to reduce blood pressure, intraocular pressure, heart rate, and has a sedative effect. n 1 cl, 2 ex
priorityDate 2017-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2133247-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-511000-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3988345-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454590832
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419575260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11846
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20179
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410540382
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID155482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7918
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572016

Total number of triples: 31.